KATHLEEN TRANSUE: Open Payments
NPI 1437183399 · CARRBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$979 in 53 payments from 10 companies in 2025. Trend: 2023 $1,220 · 2024 $1,166 · 2025 $979
Food & beverage: $979
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 14 | $306 |
| Teva Pharmaceuticals USA, Inc. | 11 | $158 |
| ABBVIE INC. | 9 | $157 |
| Neurocrine BioSciences, Inc. | 6 | $119 |
| Alkermes, Inc. | 3 | $54 |
| Supernus Pharmaceuticals, Inc. | 3 | $53 |
| Lundbeck LLC | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Janssen Pharmaceuticals, Inc | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: FANAPT, VRAYLAR, INGREZZA, AUSTEDO XR, UZEDY, REXULTI, ARISTADA, Qelbree.
Industry payments across NC — which companies pay providers there.
